Frequency of creatine kinase elevation during treatment with fluvastatin.

1. Bhatnagar D. Hypertriglyceridaemia. In: Betteridge DJ, Illingworth DR, Shepherd J, eds. Lipoproteins in Health and Disease. London, UK: Edward Arnold, 1999:737–751. 2. Wierzbicki AS, Reynolds TM. Familial hyperchylomicronaemia. Lancet 1997; 348:1524. 3. Heck AM, Yanovski JA, Calis KA. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 2000;20:270–279. 4. van Greevenbroek MM, de Bruin TW. Chylomicron synthesis by intestinal cells in vitro and in vivo. Atherosclerosis 1998;141(suppl 1):S9–S16. 5. Royal College of Physicians Working Party. Clinical management of overweight and obese patients. Royal College of Physicians, London, United Kingdom, 1998. 6. Illingworth DR, O’Malley JP. The hypolipidemic effects lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia. Metabolism 1990;39:403–409. 7. Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, Weiss SR, Crockett SE, Kaplan RA, Comstock J, et al. Role of orlistat in the treatment of obese patients with type 2 diabetes. Diabetes Care 1998;21:1288–1294.